EDWARDS LIFESCIENCES ENTERS INTO AGREEMENT TO ACQUIRE CARDIAQ

Press release:

EDWARDS LIFESCIENCES ENTERS INTO AGREEMENT TO ACQUIRE CARDIAQ

IRVINE, CA, July 10, 2015 – Edwards Lifesciences Corporation (NYSE: EW), the global leader in
the science of heart valves and hemodynamic monitoring, today announced that it has agreed to
acquire CardiAQ Valve Technologies, Inc., a privately held company and developer of a
transcatheter mitral valve replacement system.

The full press release is available on Advent Life Sciences website.

Back